Beta Drugs Limited
Share Price Target & Analysis
NSE:BETA
VWAP
Open
Close
High
Low
52 Week High
0.00 (0%)
BETA
(Miscellaneous)Indecisive
52 Week Low
EPS
PE
PB
Uncertain
Quality
Unclear
Valuation
#Analysis
NSE: BETA Share Price Financial Analysis & Valuation
Beta Drugs Limited (BETA) is broadly categorized in Miscellaneous segment industry which deals in vertical.
It is one of Penny Stocks company with Market Capitalization of Rs 0 (in Cr). Total number of free float shares are 0 (in Lacs).
Beta Drugs Limited is listed on NSE with Exchange ID - #N/A and trading code is NSE:BETA with short name .
In the past 1 year, Beta Drugs Limited has declared an equity dividend of Rs 0 per share. At the current share price of BETA at Rs 0.00, this results in a dividend yield of zero %.
As per the Fundamental Analysis of NSE:BETA, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine BETA underlying value and future prospects. All of this data is available in BETA financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:BETA, it is clearly understood that BETA is Uncertain performer in terms of earnings and profit margins with an EPS of 0.
Valuation of the Stock: The current valuation of BETA stock is like Unclear which means currently the stock is Confusing. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of BETA whether to BUY this stock at current valuation.
Now, the main question is whether to BUY or SELL, NSE:BETA at current valuation.
As per latest Analysis No. #37:-
⇑ STRONG BUY BETA if All Greens
⇗ BUY BETA (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD BETA (With Stop Loss) if only 1 Green
⇘ SELL BETA if NO Green Indicator
NSE Code |
NSE: BETA |
BETA Share Price Today |
0.00 |
BETA Share Price Target Prediction for 2024 ^ |
0 - 0 |
BETA Share Price Target Prediction for 2025*^ |
0 - 0 |
BETA Share Price Target Prediction for 2026*^ |
0 - 0 |
BETA Share Price Target Prediction for 2027*^ |
0 |
BETA Share Price Target Prediction for 2028*^ |
0 |
BETA Share Price Target Prediction for 2030*^ |
0 |
| BETA Current Book Value 2023 |
Data Not Available |
*Beta Drugs Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^BETA share price target prediction for 2024 2025 & 2026 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
BETA Technical Analysis
Candlestick Pattern: @1209.6| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 1278.86 | SELL | 1273.16 | SELL |
| MA_12 | 1305.23 | SELL | 1298.38 | SELL |
| MA_20 | 1326.84 | SELL | 1305.17 | SELL |
| MA_32 | 1315.7 | SELL | 1306.94 | SELL |
| MA_50 | 1283.55 | SELL | 1306.3 | SELL |
| MA_100 | 1326.37 | SELL | 1290.76 | SELL |
| MA_200 | 1185.8 | BUY | 1187.96 | BUY |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 1235.23 | OverSold |
| MACD | -11.46 | SELL |
| ADX | 10.71 | NO or Weak Trend |
| DMI (+/-) | 18.34 / 28.6 | Downtrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 38.47 | Neutral |
| STOCHASTIC_K (Fast) | 32.97 | Neutral |
| STOCHASTIC_D (Slow) | 52.78 | Neutral |
| CCI | -179.99 | SELL |
| PSAR | 1387.25 | SELL |
| TRUE RANGE | 175 | BUY |
| ATR | 65.37 | BUY |
| WILLIAMS R | -84.27 | Oversold |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 0 | Oversold |
| STOCHASTIC RSI D | 65.38 | Neutral |
| MOMENTUM | -92.4 | SELL |
| Duration | Value |
|---|---|
| 1 Year | 58.07% |
| 3 Months | -12.31% |
| 1 Month | -7.1% |
| 1 Week | -6.95% |
| Action | Overall (%) |
|---|---|
| BUY | 13% |
| NEUTRAL / HOLD | 20% |
| SELL | 67% |
Most popular Questions & Answers about BETA
Beta Drugs Limited stock last traded price is 0.00. BETA share price moved Down by 0% from its previous close of Rs 0.
Beta Drugs Limited share price trend is Down with a total of 0 stocks traded till now. It has touched an intraday high of Rs 0 and an intraday low of Rs 0. The BETA trading at 0.00, Down by Rs. 0.00, or 0 percent which suggests that most of the Traders are anticipating that the price of BETA share should go Down and the Stop Loss will be around 0.
The market cap of Beta Drugs Limited is ₹0 (in Cr) as of May 17, 2024.
The current price to earning ratio for Beta Drugs Limited as of May 17, 2024 is 0.
The current price to book ratio for Beta Drugs Limited as of May 17, 2024 is N/A.
The highest price of Beta Drugs Limited stock is ₹0 in the last 52-week.
The lowest price of Beta Drugs Limited stock is ₹0 in the last 52-week.
Beta Drugs Limited share trading at ₹0.00, Down by Rs. 0.00, or 0 percent which suggests that most of the traders are anticipating that the price of BETA share should go Down.
In 2023, Stock price target for Beta Drugs Limited (BETA) are ₹0 on downside and ₹0 on upside. Beta Drugs Limited share price target is based on current financial year earings of the company.
In 2024, Stock price target for Beta Drugs Limited (BETA) are ₹0 on downside and ₹0 on upside. Beta Drugs Limited share price target is based on forecasted future earnings of the company.
In 2025, Stock price target for Beta Drugs Limited (BETA) are ₹0 on downside and ₹0 on upside. Beta Drugs Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Beta Drugs Limited (BETA) will be around ₹0 Beta Drugs Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of BETA.
As per the fundamental analysis of Beta Drugs Limited (BETA), it is of Uncertain quality in terms of earnings and profit margins with an EPS of 0.